日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The deubiquitinase USP44 enhances cisplatin chemosensitivity through stabilizing STUB1 to promote LRPPRC degradation in neuroblastoma

去泛素化酶USP44通过稳定STUB1促进LRPPRC降解,从而增强神经母细胞瘤对顺铂化疗的敏感性。

Zeng, Liang; Li, Ying-Qing; He, Shi-Wei; Xu, Hui; Zhang, Ruizhong; Chen, Kai; Qin, Liang-Jun; Zhu, Xun-Hua; Li, Yi-Lin; Li, Le; Liu, Na; Wang, Hai-Yun

Degradation of IRF6 by TRIM59 in tumor cells triggers PGM1-mediated glycolysis to regulate cell proliferation in neuroblastoma.

肿瘤细胞中 TRIM59 对 IRF6 的降解会触发 PGM1 介导的糖酵解,从而调节神经母细胞瘤的细胞增殖

Zeng Liang, Xu Hui, Li Meng, Qin Liang-Jun, Chen Kai, Wang Feng-Hua, Li Xiaomin, Yang Tianyou, Miao Lei, Wang Hai-Yun

CD20(high)CD138(low) tumor-infiltrating lymphocytes predominantly related to cytokine‒cytokine receptor interactions are associated with favorable outcomes in neuroblastoma patients

CD20(高)CD138(低)肿瘤浸润淋巴细胞主要与细胞因子-细胞因子受体相互作用相关,与神经母细胞瘤患者的良好预后相关。

Qin, Liang-Jun; Xu, Hui; Li, Li-Ping; Li, Shu-Hua; Xu, Shuo-Yu; Chen, Kai; Yang, Tianyou; Wang, Feng-Hua; Zuo, Liandong; Zeng, Liang; Wang, Hai-Yun

Cross-cohort analysis identified an immune checkpoint-based signature to predict the clinical outcomes of neuroblastoma

跨队列分析确定了一种基于免疫检查点的特征,可用于预测神经母细胞瘤的临床结局。

Zeng, Liang; Xu, Hui; Li, Shu-Hua; Xu, Shuo-Yu; Chen, Kai; Qin, Liang-Jun; Miao, Lei; Wang, Fang; Deng, Ling; Wang, Feng-Hua; Li, Le; Fu, Sha; Liu, Na; Wang, Ran; Li, Ying-Qing; Wang, Hai-Yun